Precision Fermentation Facility to Open in Decatur in 2027
The new pilot site will offer startups fee-for-service access to industrial-scale fermentation and purification equipment.
Updated on Oct. 26, 2026 in Manufacturing
Live Poll
Do you believe partnerships with large established companies are necessary for startup success?
Primient is scheduled to open its Illinois Pilot Research and Operations Optimization Facility in Decatur in May 2027. This precision fermentation site provides startups with fee-for-service access to scale-up manufacturing capabilities.
Why it matters
The facility is designed to help companies navigate the valley of death between lab-scale development and commercial-scale production. By providing access to fermentation and purification equipment, it allows firms to validate production technology and economic models before full commercial deployment.
The new site features fermentation equipment with capacities ranging from 1,500 liters to 10,000 liters. This specialized infrastructure bridges the gap between laboratory testing and the full-scale industrial manufacturing capabilities currently maintained by Primient at sites in Indiana and Tennessee.
The players
Primient
An industrial manufacturer formed in 2022 that produces bio-based ingredients and operates multiple manufacturing sites in the United States.
The details
Operated as a standalone fee-for-service entity, the facility provides 24-hour support to assist clients with scale-up challenges. It features interchangeable downstream equipment, enabling operators to test multiple purification processes for their specific products. This flexibility allows companies to refine their production models while maintaining a focus on technical and economic viability at a meaningful scale.
Timeline
May 2027: The iPROOF facility is scheduled to open.
2022: Primient was formed following the sale of a primary products business by Tate & Lyle.
Market Landscape
The facility directly addresses the industry-wide valley of death in bioprocessing, where many startups struggle to transition from benchtop development to commercial viability. This expansion follows a broader industry trend of establishing specialized pilot capacity to de-risk production technology.
Operators in the bio-based sector should monitor the upcoming 2027 launch to assess whether utilizing a fee-for-service partner could reduce the capital expenditure required for internal scaling. This model allows businesses to stress-test production economics before committing to permanent infrastructure investments.
The takeaway
The facility offers a strategic option for firms looking to avoid the high costs of building dedicated pilot infrastructure. Operators should track the facility's capacity utilization as a signal for the broader feasibility of mid-scale precision fermentation economics.
Further reading
For more on industry infrastructure, visit Manufacturing.
Source note: This article includes information reported by AgFunderNews.
Live Poll
Do you believe partnerships with large established companies are necessary for startup success?
